Radiology and Oncology最新文献

{"title":"Erratum: Visual versus automated CT perfusion for outcome prediction in anterior circulation stroke treated with mechanical thrombectomy.","authors":"Igor Rigler, Tina Gspan, Alja Longo, Janja Pretnar Oblak","doi":"10.2478/raon-2026-0056","DOIUrl":"https://doi.org/10.2478/raon-2026-0056","url":null,"abstract":"","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum: CT-guided ¹²⁵I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study.","authors":"Zixiong Chen, Xiaobo Fu, Zhenkang Qiu, Maoyuan Mu, Weiwei Jiang, Guisong Wang, Zhihui Zhong, Han Qi, Fei Gao","doi":"10.2478/raon-2026-0057","DOIUrl":"https://doi.org/10.2478/raon-2026-0057","url":null,"abstract":"","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Electrochemotherapy for cutaneous tumors combined with tumor irradiation before or after treatment: feasibility, safety, and effectiveness.","authors":"Giulia Bertino, Marta Minuti, Julie Gehl, Erika Kis, Hadrian Nassabi, Michele Pio Grieco, Giuseppe Riva, Matteo Mascherini, Francesca De Terlizzi, Maja Cemazar, Gregor Sersa","doi":"10.2478/raon-2026-0051","DOIUrl":"10.2478/raon-2026-0051","url":null,"abstract":"<p><strong>Background: </strong>Electrochemotherapy (ECT) can be performed on tumors in patients that precedes tumor irradiation or on recurrent tumors after tumor irradiation. In this study we evaluated the feasibility, safety and effectiveness of the combined ECT and tumor irradiation (radiotherapy, RT) on different tumors in the head and neck region.</p><p><strong>Patients and methods: </strong>For the present cohort analysis, patients were selected from the Insp-ECT database, based on the following criteria: presence of head and neck lesions of any histological origin, treatment with both ECT and RT in any sequence, and a maximum interval of 12 months between the two treatments. The patients were treated with ECT followed by RT (ECT → RT) or RT followed by ECT (RT → ECT), in both cases because the first treatment resulted in incomplete response or subsequent relapse. In the case of ECT → RT the meantime interval was 5.7 months and in the case of RT → ECT 7.6 months. The minimal time interval between the treatments was 1 month.</p><p><strong>Results: </strong>Treatment with ECT with bleomycin was feasible in all patients, treated either before or after RT. Included were 37 patients with the head and neck lesions. The combined treatment was performed predominantly on older population of patients with the age range from 50 to 96 years, median over 80 years. Importantly, in the group ECT → RT the major reason for RT was partial response (67%) after ECT. While, in the RT → ECT group the major reason for subsequent ECT was 58% of stable or progressive disease (failure to treatment). In both groups local symptoms decreased, like ulceration, odour and suppuration of tumors. In the ECT → RT group, the short-term response after 2 months was high, with 89% objective responses. In contrast, the RT → ECT group had a significantly lower rate, with 58% objective responses. At 24-month progression free survival (PFS) was 68% in the ECT → RT group and 20% in the RT → ECT group (p = 0.0101). The overall progression free survival Kaplan-Meier curves also differed significantly (log-rank p = 0.0232).</p><p><strong>Conclusions: </strong>The combined treatment of ECT and RT is feasible, safe, and effective in elderly patients. The findings suggest that ECT may have particular value as a neoadjuvant treatment before RT, especially for bulky, ulcerated, or symptomatic lesions in this population.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"427-435"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13554300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.","authors":"Ana Perpar, Petra Georg, Ajra Secerov Ermenc","doi":"10.2478/raon-2026-0036","DOIUrl":"10.2478/raon-2026-0036","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer is a common malignancy. Advancements in multimodality treatment have improved outcomes. About 2-10% of patients will have a local recurrence even after optimal treatment. Salvage surgical treatment is the treatment of choice, however, in posterior and lateral recurrences, surgery is linked to a high rate of treatment-related morbidity. Some recurrences remain unresectable even after neoadjuvant treatment.</p><p><strong>Materials and methods: </strong>A systematic literature review was performed to search for studies on curative-intent radiation therapy (RT) with photons, stereotactic body radiation therapy (SBRT) and particle beam therapy. The aim of the literature search was to define the role of particle therapy in the treatment of patients with unresectable or inoperable local recurrences of rectal cancer where neoadjuvant treatment is unlikely to result in downstaging, leaving patients with RT as the only curative treatment option.</p><p><strong>Results: </strong>32 studies which fulfil the criteria were identified. In general, SBRT and particle beam therapy permitted the application of significantly higher doses to the target without a concomitant increase in treatment-related toxicities.</p><p><strong>Conclusions: </strong>For unresectable and inoperable locally recurrent rectal cancer ablative radiotherapy techniques such as SBRT and particle beam therapy offer a curative treatment approach as an alternative to surgery. SBRT can be offered for small local and nodal recurrences, while particle beam therapy can be offered for larger recurrences and complex shapes spanning several anatomical compartments as well. Further research is needed to stratify patients according to their need and eligibility for the different possible modalities of curative-intent RT.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"323-331"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"¹⁸F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience.","authors":"Milica Kotur, Strahinja Odalovic, Jelena Petrovic, Nikola Pantic, Isidora Grozdic Milojevic, Dragana Sobic Saranovic, Predrag Sabljak, Vera Artiko","doi":"10.2478/raon-2026-0047","DOIUrl":"10.2478/raon-2026-0047","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate differences among three patient groups with suspected recurrent esophageal carcinoma, defined by ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) findings, in quantitative and semiquantitative PET/CT parameters and serum tumor markers, and to assess their impact on progression-free survival (PFS) and overall survival (OS).</p><p><strong>Patients and methods: </strong>This retrospective cohort study included 77 patients with positive ¹⁸F-FDG PET/CT findings between January 2014 and December 2025. Based on ¹⁸F-FDG PET/CT findings, patients were classified into three groups: G1 (isolated locoregional recurrence), G2 (isolated metastases), and G3 (both locoregional disease and metastases). Semiquantitative and quantitative ¹⁸F-FDG PET/CT parameters, histopathological characteristics, and blood tumor marker levels were compared among the groups. For survival analysis, patients were stratified into low and high groups according to the median value of each parameter.</p><p><strong>Results: </strong>Elevated carcinoembryonic antigen (CEA) levels were significantly more frequent in G2 and G3 compared with G1 (p = 0.005), while no significant difference was observed for carbohydrate antigen 19-9 (CA19-9) levels (p = 0.280). Significant differences in all analyzed ¹⁸F-FDG PET/CT parameters were found among the three groups, with the highest values in G3. Patients with lower maximal standardized uptake values (SUVmax) and SUVmean values demonstrated significantly longer PFS and OS. Lower metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values were associated with significantly longer progression-free survival (PFS), while overall survival (OS) was also longer, although without statistical significance.</p><p><strong>Conclusions: </strong>Studies stratifying patients by isolated locoregional recurrence, isolated metastases, and combined locoregional/metastases on ¹⁸F-FDG PET/CT remain limited. Our findings suggest that disease spread patterns and semiquantitative/quantitative ¹⁸F-FDG PET/CT parameters may provide important prognostic value in patients with esophageal carcinoma.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"346-355"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Timed saliva sampling as a new reliable marker for assessing iodine intake.","authors":"Adrijana Oblak, Jernej Imperl, Mitja Kolar, Gregor Marolt, Blaz Krhin, Katja Zaletel, Simona Gaberscek","doi":"10.2478/raon-2026-0045","DOIUrl":"10.2478/raon-2026-0045","url":null,"abstract":"<p><strong>Background: </strong>Iodine is an essential component of thyroid hormones. Therefore, sufficient iodine intake is important for adequate thyroid function. Measuring the urinary iodine concentration (UIC) is the recommended method for assessing population iodine intake, but it has certain drawbacks. In addition to urine, iodine is also excreted into saliva. Therefore, the aim of our work was to determine whether salivary iodine concentration (SLIC) measurement could replace UIC measurements, even a gold standard, urinary iodine excretion (UIE) in the 24-hour urine. We also evaluated the influence of saliva collection time on SLIC measurements.</p><p><strong>Subjects and methods: </strong>We invited adult volunteers who first provided 24-hour urine and saliva samples collected on the same day at home, strictly according to the protocol. UIC and SLIC before and after meals were measured using the Sandell-Kolthoff method, comparable to inductively coupled plasma mass spectrometry.</p><p><strong>Results: </strong>The study included 104 healthy participants from whom all biological samples were completely collected. Importantly, none of them was taking thyroid medication or iodine supplements and all were without thyroid disease. A very good correlation of SLIC values at 60 and 120 min after the first and second meal and 30 min after the second, third, and fourth meals with UIE was observed (P>0.05).</p><p><strong>Conclusions: </strong>We found an excellent correlation between SLIC values and UIE, where the SLIC value depends on the sampling timing and/or number of meals. SLIC measurement could replace UIE measurement and represents an important and possible new biomarker for assessing iodine intake.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"339-345"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13554299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does age have an impact on surgical and oncologic outcomes after curative resection for gastric cancer: a ten-year single-centre retrospective study.","authors":"Matjaz Horvat, Stojan Potrc, Nuhi Arslani","doi":"10.2478/raon-2026-0044","DOIUrl":"10.2478/raon-2026-0044","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer remains a major health burden in Slovenia, particularly among elderly patients. With increasing life expectancy, a growing number of patients aged ≥ 70 years are expected to undergo curative surgery. This study compared clinical, surgical, and oncologic outcomes between elderly (≥ 70 years) and younger (< 70 years) patients with gastric cancer.</p><p><strong>Patients and methods: </strong>A single-center retrospective cohort study included patients who underwent curative-intent surgery for gastric adenocarcinoma between 2015 and 2024. Patients were stratified by age. Demographic data, comorbidities, tumor characteristics, surgical variables, postoperative complications (Clavien-Dindo classification), and overall survival (OS) were analyzed. Survival was assessed using the Kaplan-Meier method, and prognostic factors were evaluated using Cox proportional hazards regression.</p><p><strong>Results: </strong>A total of 433 patients were included (229 < 70 years; 204 ≥ 70 years). Elderly patients had higher American Society of Anesthesiologists (ASA) scores and a higher incidence of major postoperative complications. R0 resection rates and surgical radicality were comparable between groups; however, elderly patients more frequently underwent subtotal gastrectomy and less extensive lymphadenectomy. Perioperative chemotherapy was more commonly administered in younger patients. Tumour characteristics and TNM stage distribution were similar between groups. Five-year OS was significantly lower in elderly patients (37.3% <i>vs</i>. 59.6%, p < 0.001).</p><p><strong>Conclusions: </strong>Curative gastric cancer surgery should not be denied based solely on chronological age. Carefully selected elderly patients can achieve acceptable surgical and oncologic outcomes, highlighting the importance of biological age and functional status in treatment decision-making.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"442-449"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548684/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical impact of trace elements as potential biomarkers for diagnosis and prediction of response to systemic treatment in gastrointestinal cancers.","authors":"Martina Rebersek, Radmila Milacic Scancar, Janez Scancar, Nezka Hribernik","doi":"10.2478/raon-2026-0023","DOIUrl":"10.2478/raon-2026-0023","url":null,"abstract":"<p><strong>Background: </strong>Gastrointestinal cancers are among the most common malignancies worldwide and, at advanced stages, remain incurable. Currently used biomarkers, such as tumour markers, have limited diagnostic value for early detection and relapse, highlighting the urgent need for more sensitive and specific markers. Trace elements are involved in numerous physiological and metabolic processes, and deregulation of their homeostasis is implicated in the carcinogenesis of various cancers, including gastrointestinal malignancies. Several basic and preclinical studies have identified the importance of trace elements in key biological processes. Recent clinical studies and retrospective analyses suggest that fluctuations in trace element levels may be associated with the development and progression of many cancers. Thus, quantitative and dynamic determination of serum trace element concentrations during treatment and follow-up represents a promising option for monitoring treatment efficacy and disease prognosis.</p><p><strong>Conclusions: </strong>Trace elements may serve as potential prognostic and predictive biomarkers for diagnosis and response to systemic treatment.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":" ","pages":"332-338"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147779457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience.","authors":"Gasper Pilko, Rok Petric","doi":"10.2478/raon-2026-0041","DOIUrl":"10.2478/raon-2026-0041","url":null,"abstract":"<p><strong>Background: </strong>Peritoneal metastases (PM) from colorectal cancer are associated with poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been proposed for selected patients, although its role remains debated. This study evaluates the efficacy and safety of CRS plus HIPEC in a single institution.</p><p><strong>Patients and methods: </strong>This retrospective study included patients with colorectal PM treated with CRS and HIPEC between 2009 and 2024. Preoperative staging involved CT and/or MRI, and all cases were discussed in a multidisciplinary team. Disease burden was assessed using the Peritoneal Cancer Index (PCI), and completeness of cytoreduction (CC score) was recorded. HIPEC was performed with oxaliplatin (360 mg/m² at 42°C for 90 minutes). Overall survival (OS) was the primary endpoint; disease-free survival (DFS) and morbidity were secondary endpoints.</p><p><strong>Results: </strong>Fifty patients (mean age 54 years) were included. Complete cytoreduction (CC-0/1) was achieved in 88% of cases, with a median PCI of 8.33. Severe complications occurred in 18% of patients, with no 30-day mortality. After a median follow-up of 34 months, median OS was 49 months; 1- and 5-year OS rates were 96% and 54%, respectively. Median DFS was 14 months. PCI, CC score, and prior surgical score (PSS) were associated with OS on univariate analysis, while PCI and CC score remained independent prognostic factors.</p><p><strong>Conclusions: </strong>CRS plus HIPEC is a feasible and effective treatment for selected patients with colorectal PM, with acceptable morbidity. Low PCI and complete cytoreduction are key predictors of improved survival.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"436-441"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Breast DCE-MRI morphological features and semi-quantitative parameters associated with upgrade to invasive carcinoma in biopsyproven DCIS.","authors":"Vladimir Urban, Zorica Milosevic, Zoran Bukumiric, Katarina Obradovic, Nina Adzic, Dragana Pavlovic-Stankovic, Ivana Petkovic, Ivana Sovic, Irena Jovanic, Igor Spurnic","doi":"10.2478/raon-2026-0043","DOIUrl":"10.2478/raon-2026-0043","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to identify imaging predictors of upgrade to invasive carcinoma (IC) in patients with biopsy-proven ductal carcinoma <i>in situ</i> (DCIS) based on morphological features and semi-quantitative parameters derived from dynamic contrast-enhanced breast magnetic resonance imaging (DCE-MRI).</p><p><strong>Patients and methods: </strong>Ninety consecutive patients with biopsy-proven DCIS who had positive findings on standard full-protocol breast DCE-MRI and subsequently underwent surgical excision with final postoperative histopathological diagnosis were included. Patients with final postoperative IC were compared with those without IC. Morphological features (lesion type, size, multifocality/multicentricity, T2-weighted (T2W) and turbo inversion recovery magnitude [TIRM] characteristics) and semi-quantitative parameters (wash-in, peak enhancement, delayed phase of the timeintensity curve [TIC], time to peak [TTP], and positive enhancement integral [PEI]) were analyzed.</p><p><strong>Results: </strong>Fifty-five patients (61.1%) had no IC, while 35 patients (38.9%) had IC on final histopathology. Patients with IC more frequently demonstrated non-mass enhancement (NME) combined with a mass, larger lesion size, multifocal or multicentric disease, T2W/TIRM hyperintensity, fast wash-in, higher peak enhancement, plateau and washout TIC patterns, higher PEI, and shorter TTP. Multivariate analysis identified NME combined with a mass, delayed-phase TIC characteristics, and TIRM hyperintensity as independent predictors of IC.</p><p><strong>Conclusions: </strong>Our study confirmed that prediction models incorporating breast DCE-MRI morphological features and semi-quantitative parameters can stratify patients with biopsy-proven DCIS by their probability of upgrade to IC. TIRM hyperintensity emerged as one of three independent predictors of IC and, to the best of our knowledge, has not been previously reported in this context.</p>","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"60 3","pages":"356-366"},"PeriodicalIF":2.3,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}